Relationship of NAT2, CYP2E1 and GSTM1/GSTT1 polymorphisms with mild elevation of liver enzymes in Brazilian individuals under anti-tuberculosis drug therapy

10Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

Abstract

The relationship of NAT2, CYP2E1 and GSTM1/GSTT1 polymorphisms with mild elevation of liver biomarkers was investigated in individuals under anti-tuberculosis drug therapy. Tuberculosis outpatients (18-70. y) with (n = 59) and without (n = 40) mild increase of liver enzymes (MILE) at two-month treatment were selected. Blood samples were obtained for DNA extraction and evaluation of serum markers of liver function. NAT2, CYP2E1 and GSTM1/. GSTT1 polymorphisms were detected by DNA sequencing, PCR-RFLP, and PCR multiplex. Frequency of NAT2* 5/* 5 genotype was higher in MILE than in non-MILE group (p = 0.04). Patients carrying NAT2* 5/* 5 genotype had increased susceptibility to MILE (OR: 9.00, 95CI: 1.46-55.48, p = 0.018). CYP2E1* 5B allele (*1A/*5B plus *5B/*5B genotypes) carriers had a trend for reduced risk for MILE (OR: 0.34, 95CI: 0.11-1.03, p = 0.056) that was confirmed by lower levels of liver markers than CYP2E1* 1A/* 1A carriers after treatment (p < 0.05). Moreover, increased post-treatment ALT, AST and total bilirubin were associated with G. STM1* 1/. GSTT1* 1 genotypes (p < 0.05). Patients taking CYP2E1 inhibitors had increased susceptibility to MILE (OR: 7.39, 95CI: 1.93-28.29, p = 0.003), which was independent of the studied polymorphisms. These results are suggestive that NAT2, CYP2E1 and GSTM1/. GSTT1 polymorphisms and concomitant use of CYP2E1 inhibitors contribute to the susceptibility to mild alterations in liver enzymes in patients under anti-tuberculosis drug therapy. © 2012 Elsevier B.V.

Cite

CITATION STYLE

APA

Forestiero, F. J., Cecon, L., Hirata, M. H., de Melo, F. F., Cardoso, R. F., Cerda, A., & Hirata, R. D. C. (2013). Relationship of NAT2, CYP2E1 and GSTM1/GSTT1 polymorphisms with mild elevation of liver enzymes in Brazilian individuals under anti-tuberculosis drug therapy. Clinica Chimica Acta, 415, 215–219. https://doi.org/10.1016/j.cca.2012.10.030

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free